Literature DB >> 13867084

Treatment of autistic schizophrenic children with LSD-25 and UML-491.

L BENDER, L GOLDSCHMIDT, D V SANKAR.   

Abstract

Entities:  

Keywords:  LYSERGIC ACID DIETHYLAMIDE/related compounds; LYSERGIC ACID DIETHYLAMIDE/therapy; SCHIZOPHRENIA/in infancy and childhood

Mesh：

Substances：

Year:  1961        PMID： 13867084     DOI： 10.1007/978-1-4684-8306-2_17

Source DB:  PubMed          Journal:  Recent Adv Biol Psychiatry        ISSN： 0376-2122


× No keyword cloud information.
  6 in total

Review 1.  Childhood autism. A review of the clinical and experimental literature.

Authors:  E M Ornitz
Journal:  Calif Med       Date:  1973-04

2.  Chronic LSD alters gene expression profiles in the mPFC relevant to schizophrenia.

Authors:  David A Martin; Danuta Marona-Lewicka; David E Nichols; Charles D Nichols
Journal:  Neuropharmacology       Date:  2014-04-03       Impact factor: 5.250

3.  Semantic inference using chemogenomics data for drug discovery.

Authors:  Qian Zhu; Yuyin Sun; Sashikiran Challa; Ying Ding; Michael S Lajiness; David J Wild
Journal:  BMC Bioinformatics       Date:  2011-06-23       Impact factor: 3.169

Review 4.  Evaluating the Potential Use of Serotonergic Psychedelics in Autism Spectrum Disorder.

Authors:  Athanasios Markopoulos; Antonio Inserra; Danilo De Gregorio; Gabriella Gobbi
Journal:  Front Pharmacol       Date:  2022-01-27       Impact factor: 5.810

Review 5.  Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders.

Authors:  Henry Lowe; Ngeh Toyang; Blair Steele; Justin Grant; Amza Ali; Lorenzo Gordon; Wilfred Ngwa
Journal:  Molecules       Date:  2022-04-14       Impact factor: 4.927

Review 6.  The Therapeutic Potential of Psilocybin.

Authors:  Henry Lowe; Ngeh Toyang; Blair Steele; Henkel Valentine; Justin Grant; Amza Ali; Wilfred Ngwa; Lorenzo Gordon
Journal:  Molecules       Date:  2021-05-15       Impact factor: 4.411
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.